Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted January 07, 2008 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        

DTCuba.com

Cuba’s pharmaceutical industry is working to expand its presence on the international market by commercializing new medicines.

Among the new medicines that might be exported during the 2008-2010 period is the pentavalent vaccine Heberpenta, which immunizes against diphtheria, tetanus, whooping cough, hepatitis B and the bacteria Haemophilus influenzae type B.

Heberpenta is produced by the company Heber Biotec S.A., which is the exclusive representative of the Genetic Engineering and Biotechnology Center and other Cuban scientific institutions.

The Cuban company will also export interferon gel to treat cervical-uterine cancer, and recombinant streptokinase (Heberkinasa), which destroys blood clots.

It also plans to commercialize a viscous solution containing Skin Growth Factor (Hebervis), which speeds up the regeneration of mucus and minimizes the secondary effects of radiotherapy treatments.

  1. Follow up post #1 added on August 06, 2008 by Neida Manzano

    esa vacuna trae efectos colaterales previa a su colocacion, y no es la primera vacuna que exiaste de ese tipo el laboratorio glaxo elaboro una vacuna que se llama infarix Hexa que proteje contra seis enfermedades y no ninguna reaccion


Would you like to add more information?


Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
Images of Cuba
Actual typewriter of Ernest Hemingway
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review



Member of the Association for the Study of the Cuban Economy